Ulcer and bleeding complications and their relationship with dyspeptic symptoms in NSAIDs users: a transversal multicenter study

Carregando...
Imagem de Miniatura
Citações na Scopus
8
Tipo de produção
article
Data de publicação
2014
Título da Revista
ISSN da Revista
Título do Volume
Editora
INFORMA HEALTHCARE
Citação
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, v.49, n.7, p.785-789, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objectives. To evaluate the prevalence of lesions and digestive complications secondary to the use of non-steroidal anti-inflammatory drugs (NSAIDs), the clinical profile seen for digestive complaints and the relation with the endoscopic findings. Methods. Prospective, multicentric, open study, evaluating consecutively 1231 patients, divided as follows: group I NSAID and group II - non-NSAID. All patients answered questionnaire to evaluate the onset, the type of clinical complaint, the use of medication and possible complications associated to digestive bleeding. Results. A total of 1213 patients were evaluated. Among them, 65% were female and 13.1% were smokers; 15.6% mentioned they ingested alcoholic beverages. The main signs and symptoms reported were epigastralgy and pyrosis (67% and 62%, respectively). The upper gastrointestinal (UGI) endoscopy was normal in 3.9% in group I and in 10.7% in group II (p < 0.001). Patient who do not use NSAID will be 2.5 times more likely to have normal UGI endoscopy (p = 0.001). The presence of erosive or ulcer lesions in the stomach and duodenum was more frequent in group I. The incidence of lesions in the stomach when compared to the duodenum is observed (erosions: 49.12% vs. 13.60%, p = 0.001; ulcers: 14.04% vs. 11.84%, p = 0.05). The risk of digestive bleeding is 12 times higher (6.14% vs. 0.51%) in those who used NSAIDs, and the stomach is the site in which bleeding occurs more frequently. Conclusions. The frequency of gastric ulcer, duodenal ulcer and digestive bleeding was higher in patients who used NSAIDs. There was no connection found between endoscopic findings and dyspeptic symptoms.
Palavras-chave
adverse effects, anti-inflammatory, drugs, duodenum injuries, esophagus injuries, multicenter studies as a subject, stomach injuries
Referências
  1. Bhatt DL, 2008, J AM COLL CARDIOL, V52, P1502, DOI 10.1016/j.jacc.2008.08.002
  2. Greenberg JD, 2009, CLIN EXP RHEUMATOL, V27, P395
  3. Hawkey CJ, 2000, GASTROENTEROLOGY, V119, P521, DOI 10.1053/gast.2000.9561
  4. Huang JQ, 2002, LANCET, V359, P14, DOI 10.1016/S0140-6736(02)07273-2
  5. Laine L, 2001, GASTROENTEROLOGY, V120, P594, DOI 10.1053/gast.2001.21907
  6. Lanza FL, 2009, AM J GASTROENTEROL, V104, P728, DOI 10.1038/ajg.2009.115
  7. Okanobu H, 2012, DIGESTION, V86, P187, DOI 10.1159/000339710
  8. Paulose-Ram R, 2005, PHARMACOEPIDEM DR S, V14, P257, DOI 10.1002/pds.983
  9. Scarpignato C, 2010, GASTROENTEROL CLIN N, V39, P433, DOI 10.1016/j.gtc.2010.08.010
  10. Singh G, 1996, ARCH INTERN MED, V156, P1530, DOI 10.1001/archinte.156.14.1530
  11. Sinha M, 2013, MEDIAT INFLAMM, DOI 10.1155/2013/258209
  12. Soylu A, 2008, WORLD J GASTROENTERO, V14, P6704, DOI 10.3748/wjg.14.6704
  13. VANE JR, 1971, NATURE-NEW BIOL, V231, P232
  14. World Health Organization, 2003, P 12 WORLD C TOB HLT